
Simon Pan
Articles
-
1 week ago |
2minutemedicine.com | Simon Pan |Alex Chan
1. While not statistically significant, the use of sotorasib plus panitumumab may have a 30% relative risk reduction in the risk of death compared to the investigator’s choice of chemotherapy in the management of Kirsten rat sarcoma viral oncogene homologue (KRAS) glycine-to-cysteine mutation at codon 12 (KRAS G12C) colorectal cancer.
-
1 month ago |
2minutemedicine.com | Simon Pan |Alex Chan
1. The usage of tenecteplase in patients with acute ischemic stroke was associated with similar effectiveness and safety compared with the use of alteplase. Evidence Rating Level: 2 (Good)Current agents used in the thrombolytic management of acute ischemic stroke include tenecteplase and alteplase.
-
1 month ago |
2minutemedicine.com | Simon Pan |Alex Chan
1. A deescalation strategy involving switching from ticagrelor to clopidogrel in patients with acute myocardial infarction (AMI) was associated with improved clinical outcomes in those with lower body mass index (BMI) but not those with higher BMI. Evidence Rating Level: 1 (Excellent)Study Rundown: The current standard of care for individuals with AMI involves percutaneous coronary intervention (PCI) followed by antiplatelet therapy.
-
1 month ago |
2minutemedicine.com | Simon Pan |Alex Chan
1. In patients with symptomatic gallbladder stones who were found to have asymptomatic concomitant common bile duct stones (CBDS), laparoscopic cholecystectomy without CBDS removal was associated with acceptable short-term outcomes. Evidence Rating Level: 2 (Good)CBDS may be found in up to 20% of individuals undergoing laparoscopic cholecystectomy for symptomatic gallstones.
-
1 month ago |
2minutemedicine.com | Simon Pan |Alex Chan
1. In patients with treatment-naive high-risk myelodysplastic syndromes (HR MDS), the use of venetoclax (14 days) plus azacitidine was well tolerated. 2. In patients with treatment-naive HR MDS, venetoclax plus azacitidine resulted in a 26-month median overall survival (mOS) rate with a complete response (CR) observed in 29.9% of patients.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →